CONCLUSION: Treatment with methylphenidate, risperidone, and combination therapy was associated with modest changes in heart rate, blood pressure, and QTc interval over three months. These findings highlight the importance of baseline and follow-up cardiovascular monitoring in children and adolescents receiving ADHD medications.
